Galderma's record H1 performance is partly fueled by a structural shift in patient demand: GLP-1 users seeking to address volume loss and skin laxity triggered by rapid weight reduction. The "Ozempic face" phenomenon—characterized by hollowing, jowling, and loss of skin elasticity—has become a clinical driver for both neuromodulators and volumizing fillers, as well as RF microneedling and biostimulator treatments.
Market
Galderma Capitalizes on GLP-1 Weight-Loss Trend—What Practices Need to Know
As patients on semaglutide and tirzepatide seek facial rejuvenation, Galderma's H1 surge reflects the medspa industry's pivot to post-GLP-1 aesthetics.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
GLP-1 users seeking facial rejuvenation are driving demand for volumizers and biostimulators alongside neuromodulators.
This trend creates both opportunity and operational complexity for independent practices. Patients on GLP-1s often require higher filler volumes and more frequent touch-ups due to accelerated metabolism and altered facial anatomy. Practices should anticipate longer consultation times, revised treatment protocols, and potential inventory planning shifts. The uptick also explains why Galderma—with its breadth across Botox, Juvéderm, and Radiesse—is outpacing single-category competitors.
Source: original report ↗
Frequently asked questions
What is Ozempic face and why are patients seeking treatment for it?
Ozempic face refers to facial volume loss, hollowing, jowling, and skin laxity that occurs as a side effect of rapid weight reduction from GLP-1 medications like semaglutide and tirzepatide. Patients are seeking neuromodulators, volumizing fillers, RF microneedling, and biostimulator treatments to restore facial fullness and tighten skin affected by these changes.
Do GLP-1 patients need more filler than regular patients?
Yes, patients on GLP-1s typically require higher filler volumes and more frequent touch-ups compared to standard patients due to accelerated metabolism and altered facial anatomy from weight loss. This means practices should plan for longer consultation times and revised treatment protocols when treating this patient population.
How should medspa practices prepare for an influx of GLP-1 patients?
Practices should anticipate longer consultation times to assess the extent of volume loss and skin laxity, revise treatment protocols to account for higher filler volumes, and adjust inventory planning to stock adequate supplies of neuromodulators and volumizing fillers. Understanding the specific facial changes caused by GLP-1 weight loss will help practices deliver better outcomes and manage patient expectations.
Why is Galderma outperforming competitors in the GLP-1 aesthetics trend?
Galderma's breadth across multiple product categories—including Botox, Juvéderm, and Radiesse—positions it to address the full range of post-GLP-1 facial concerns in a single relationship. Single-category competitors cannot offer the comprehensive solution that practices need to treat volume loss, skin laxity, and dynamic wrinkles in GLP-1 patients.
What aesthetic treatments work best for Ozempic face?
The most effective treatments for Ozempic face include volumizing fillers like Juvéderm to restore lost facial volume, neuromodulators like Botox to address dynamic wrinkles, RF microneedling to tighten skin, and biostimulator treatments like Radiesse to stimulate collagen production. A combination approach tailored to each patient's specific anatomy and weight-loss pattern typically yields the best results.
How does GLP-1 metabolism affect filler longevity?
GLP-1 medications accelerate overall metabolism, which can shorten the duration of filler results compared to non-GLP-1 patients. This means patients on these medications will likely need more frequent touch-ups and higher initial filler volumes to achieve and maintain desired results.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.